(Q40139757)

17 September 2017

1 reference

title

Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments (English)

1 reference

17 September 2017

Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatments (English)

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

26 September 2023

author name string

P. Willner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6318882

26 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6318882

26 September 2023

publication date

1 December 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0165017383900073?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

https://api.elsevier.com/content/article/PII:0165017383900073?httpAccept=text/plain

26 September 2023

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

26 September 2023

1 reference

17 September 2017

287

1 reference

17 September 2017

237-246

1 reference

17 September 2017

3

1 reference

Antidepressants and dopamine autoreceptors: implications for both a novel means of treating depression and understanding bipolar illness

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Prolactin changes in major depressive disorders

26 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Lack of effect of repeated electroconvulsive shock on [3H]spiroperidol and [2H]5-hydroxytryptamine binding and cholinergic parameters in rat brain.

26 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effects of electroconvulsive treatment on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats

26 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon

26 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms

26 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

26 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol

26 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain

26 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats.

26 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Prediction of tricyclic antidepressant response: a critical review

26 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli

26 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

d -Amphetamine-Induced Inhibition of Central Dopaminergic Neurons: Mediation by a Striato-Nigral Feedback Pathway

26 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effects of antidepressant agents on the synthesis of brain monoamines

26 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

26 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment

26 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Repeated tricyclic antidepressants induce a progressive 'switch' in the electrophysiological response of dopamine neurons to autoreceptor stimulation

26 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment

26 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Sensory stimuli alter the discharge rate of dopamine (DA) neurons: evidence for two functional types of DA cells in the substantia nigra

26 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Reciprocal influences of activating and immobilizing stimuli on the activity of nigrostriatal dopamine neurons

26 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients

26 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Peripheral ?-adrenoreceptor and central dopamine receptor activity in depressive patients

26 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.

26 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock.

26 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters

26 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Modulation of dopamine-mediated behavioural responses by antidepressants: Effects of single and repeated treatment

26 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks

26 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs

26 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

The behavioral effects of amphetamine on REM deprived rats.

26 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats

26 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-Amphetamine and apomorphine

26 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Antidepressant drugs and dopamine uptake in different brain regions

26 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

The sleep therapies of depression.

26 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors

26 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour

26 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions—III the effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses

26 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine

26 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Self-inhibition by Dopaminergic Neurons

26 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Antidepressant drugs affect dopamine uptake

26 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbens

26 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors

26 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Role of dopamine in d-amphetamine-induced discriminative responding

26 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants.

26 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex

26 September 2023

56

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs

26 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Brain levels of imipramine and desipramine after combined treatment with these drugs in rats

26 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Tricyclic antidepressive drugs and dopamine-sensitive adenylate cyclase from rat brain striamtum

26 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

26 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain

26 September 2023

61

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment

26 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.

26 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effect of sleep deprivation on dopamine receptor function in normal subjects

26 September 2023

64

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

26 September 2023

Q64866855

65

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Reduced presynaptic dopamine receptor density after chronic antidepressant treatment in rats.

26 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain.

26 September 2023

67

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Chronic treatment with antidepressant drugs: Potentiation of apomorphine-induced aggressive behaviour in rats

26 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei.

26 September 2023

70

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Behavioural responses to stereotactically controlled injections of monoamine neurotransmitters into the accumbens and caudate-putamen nuclei

26 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Lack of effect of tricyclic antidepressants on serum prolactin levels

26 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS

26 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines.

26 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Direct evidence for presynaptic and postsynaptic dopamine receptors in brain

26 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

The symptoms of major depressive illness

26 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

26 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens

26 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

26 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain

26 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

The effect of imipramine and lithium on α- and β-receptor binding in rat brain

26 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors

26 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid

26 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effect of neuroleptics and tricyclic antidepressants upon D-amphetamine discrimination

26 September 2023

93

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats

26 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine

26 September 2023

96

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

26 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

REM sleep deprivation induces subsensitivity of dopamine receptors mediating sedation in rats

26 September 2023

99

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Dopamine Auto- and Postsynaptic Receptors: Electrophysiological Evidence for Differential Sensitivity to Dopamine Agonists

26 September 2023

100

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine

26 September 2023

101

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Presynaptic receptor systems in catecholaminergic transmission

26 September 2023

102

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine

26 September 2023

103

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Changes in rat brain monoamine turnover following chronic antidepressant administration

26 September 2023

104

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

A neuroendocrine study of supersensitivity in tardive dyskinesia.

26 September 2023

105

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effect of antidepressant drugs on serotonergic and adrenergic receptors

26 September 2023

106

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors

26 September 2023

107

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Subsensitivity of catecholaminergic neurons to direct acting agonists after single or repeated electroconvulsive shock

26 September 2023

108

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Does REM Sleep Deprivation Induce a Supersensitivity of Dopaminergic Receptors in the Rat Brain?

26 September 2023

109

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Do antidepressants induce dopamine autoreceptor subsensitivity?

26 September 2023

111

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

The effects of electroconvulsive shock on the discriminative stimulus properties of d-amphetamine and apomorphine: evidence for dopamine receptor alteration subsequent ECS.

26 September 2023

112

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Effects of tricyclic antidepressants on human plasma levels of TSH, GH and prolactin

26 September 2023

113

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats

26 September 2023

114

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Dopamine and depression: A review of recent evidence. I. Empirical studies

26 September 2023

115

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Dopamine and depression: A review of recent evidence. II. Theoretical approaches

26 September 2023

116

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine

26 September 2023

118

1 reference

https://api.crossref.org/works/10.1016/0165-0173(83)90007-3

26 September 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6318882

26 September 2023

1 reference